| 2014 |
Cardiovascular risk associated with sodium-containing medicines
10.1517/14740338.2014.970163
Authors: L. Wei, I. Mackenzie, T. MacDonald, J. George |
| 2021 |
Cardiovascular risk factors early in the course of treatment in people with type 2 diabetes without established cardiovascular disease: A population-based observational retrospective cohort study
10.1111/dme.14697
Authors: K. Khunti, C. Hertz, L. Husemoen, E. Mocevic, R. Nordsborg, J. Piltoft, S. Bain |
| 2021 |
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study
10.1007/s40264-021-01095-7
Authors: V. Hoffman, J. Hallas, M. Linder, A. Margulis, B. Suehs, A. Arana, K. Phiri, C. Enger, L. Horter, I. Odsbu, M. Olesen, S. Perez-Gutthann, Y. Xu, N. Kristiansen, K. Appenteng, S. de Vogel, J. Seeger |
| 2022 |
Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings
10.1007/s00125-021-05640-y
Authors: K. Dziopa, F. Asselbergs, J. Gratton, N. Chaturvedi, A. Schmidt |
| 2021 |
Cardiovascular risk profiles: A cross-sectional study evaluating the generalisability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trials Rewind, Leader and Sustain-6 to the real-world type 2 diabetes population in the UK
10.1111/dom.14580
Authors: J. Webb, J. Mount, L. von Arx, J. Rachman, D. Spanopoulos, R. Wood, T. Tritton, O. Massey, I. Idris |
| 2017 |
Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study
10.2147/clep.s127775
Authors: J. Dollerup, J. Vestbo, T. Murray-Thomas, A. Kaplan, R. Martin, E. Pizzichini, M. Pizzichini, A. Burden, J. Martin, D. Price |
| 2019 |
Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study
10.1007/s40264-019-00835-0
Authors: A. Gilsenan, J. Fortuny, M. Cainzos-Achirica, O. Cantero, R. Flynn, L. Garcia-Rodriguez, A. Harding, B. Kollhorst, P. Karlsson, L. Linner, T. MacDonald, I. Odsbu, E. Plana, A. Ruigomez, T. Schink, R. Ziemiecki, E. Andrews |
| 2017 |
Cardiovascular safety of vildagliptin in patients with type 2 diabetes: A European multi-database, non-interventional post-authorization safety study
10.1111/dom.12951
Authors: R. Williams, F. de Vries, W. Kothny, C. Serban, S. Lopez-Leon, C. Chu, R. Schlienger |
| 1993 |
Care of schizophrenia in general practice
Authors: I. Nazareth, M. King, A. Haines, S. Tai, G. Hall |
| 1995 |
Care of schizophrenia in general practice: the general practitioner and the patient
Authors: I. Nazareth, M. King, S. Davies |
| 2013 |
Case-control analysis on metformin and cancer of the esophagus
10.1007/s10552-013-0253-6
Authors: C. Becker, C. Meier, S. Jick, M. Bodmer |
| 2005 |
Case-mix and variation in specialist referrals in general practice
Authors: C. Sullivan, R. Omar, G. Ambler, A. Majeed |
| 2003 |
Cataract and the use of statins: a case-control study
Authors: L. Smeeth, R. Hubbard, A. Fletcher |
| 2018 |
Cataract in patients with diabetes mellitus-incidence rates in the UK and risk factors
10.1038/s41433-017-0003-1
Authors: C. Becker, C. Schneider, S. Aballea, C. Bailey, R. Bourne, S. Jick, C. Meier |
| 2023 |
Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England
10.1136/thorax-2022-219320
Authors: H. Whittaker, K. Rothnie, J. Quint |
| 2010 |
Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K
10.1111/j.1365-2133.2010.09941.x
Authors: K. Abuabara, R. Azfar, D. Shin, A. Neimann, A. Troxel, J. Gelfand |
| 2013 |
Cause-specific mortality of people with Barrett\textquoterights esophagus compared with the general population: a population-based cohort study
10.1053/j.gastro.2013.02.050
Authors: M. Solaymani-Dodaran, T. Card, J. West |
| 2021 |
Causes of death among people who used illicit opioids in England, 2001-18: a matched cohort study
10.1016/s2468-2667(21)00254-1
Authors: D. Lewer, T. Brothers, N. Van Hest, M. Hickman, A. Holland, P. Padmanathan, P. Zaninotto |
| 2012 |
Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study
10.1111/j.1468-1331.2012.03668.x
Authors: A. Lalmohamed, M. Bazelier, T. van Staa, B. Uitdehaag, H. Leufkens, A. de Boer, F. de Vries |
| 2015 |
Causes of death in people with coeliac disease in England compared with the general population: a competing risk analysis
10.1136/gutjnl-2014-308285
Authors: Abdul Sultan, C. Crooks, T. Card, L. Tata, K. Fleming, J. West |
| 2005 |
Cesarean delivery in the United Kingdom: time trends in the general practice research database
10.1097/01.AOG.0000160429.22836.c0
Authors: C. Black, J. Kaye, H. Jick |
| 2009 |
Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)\textendasha pharmacoepidemiological and qualitative study
10.3310/hta13490
Authors: I. Wong, P. Asherson, A. Bilbow, S. Clifford, D. Coghill, R. DeSoysa, C. Hollis, S. McCarthy, M. Murray, C. Planner, L. Potts, K. Sayal, E. Taylor |
| 2021 |
Challenges and Pitfalls of Using Repeat Spirometry Recordings in Routine Primary Care Data to Measure FEV(1) Decline in a COPD Population
10.2147/por.s319965
Authors: H. Whittaker, S. Kiddle, J. Quint |
| 2018 |
Change in Albuminuria and Risk of Renal and Cardiovascular Outcomes: Natural Variation Should Be Taken into Account
10.1016/j.ekir.2018.04.004
Authors: M. Smith, W. Herrington, M. Weldegiorgis, F. Hobbs, C. Bankhead, M. Woodward |
| 2021 |
Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades
10.1136/rmdopen-2021-001888
Authors: S. Crossfield, H. Marzo-Ortega, S. Kingsbury, M. Pujades-Rodriguez, P. Conaghan |
| 2003 |
Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study
Authors: J. Kaye, B. Bradbury, H. Jick |
| 2021 |
Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression
10.1053/j.ajkd.2021.02.335
Authors: B. Neuen, M. Weldegiorgis, W. Herrington, T. Ohkuma, M. Smith, M. Woodward |
| 2017 |
Changes in HbA1c and weight after initiation of second-line therapy in patients with type 2 diabetes in clinical practice.
Authors: J.P.H. Wilding, T. Godec, K. Khunti, S. Pocock, R. Fox, L. Smeeth, P. Clauson, P. Fenici, N. Hammar, J. Medina |
| 2018 |
Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink
10.1186/s12916-018-1085-8
Authors: J. Wilding, T. Godec, K. Khunti, S. Pocock, R. Fox, L. Smeeth, P. Clauson, P. Fenici, N. Hammar, J. Medina |
| 2022 |
Changes in heart failure management and long-term mortality over 10 years: observational study
10.1136/openhrt-2021-001888
Authors: A. Bottle, R. Newson, P. Faitna, B. Hayhoe, M. Cowie |
| 2011 |
Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study
10.1136/ard.2010.131110
Authors: D. Prieto-Alhambra, M. Javaid, J. Maskell, A. Judge, M. Nevitt, C. Cooper, N. Arden |
| 2015 |
Changes in rates of recorded depression in English primary care 2003-2013: Time trend analyses of effects of the economic recession, and the GP contract quality outcomes framework (QOF)
10.1016/j.jad.2015.03.040
Authors: T. Kendrick, B. Stuart, C. Newell, A. Geraghty, M. Moore |
| 2008 |
Changes in the characteristics of patients prescribed selective cyclooxygenase 2 inhibitors after the 2004 withdrawal of rofecoxib
10.1002/art.23925
Authors: E. Setakis, H. Leufkens, T. van Staa |
| 2016 |
Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study
10.1183/13993003.01033-2015
Authors: J. Quint, E. Millett, M. Joshi, V. Navaratnam, S. Thomas, J. Hurst, L. Smeeth, J. Brown |
| 2021 |
Changes in the pharmacological management of rheumatoid arthritis over two decades
10.1093/rheumatology/keaa892
Authors: S. Crossfield, M. Buch, P. Baxter, S. Kingsbury, M. Pujades-Rodriguez, P. Conaghan |
| 2020 |
Changes in the presenting symptoms of lung cancer from 2000-2017: a serial cross-sectional study of observational records in UK primary care
10.3399/bjgp20X708137
Authors: S. Chowienczyk, S. Price, W. Hamilton |
| 2014 |
Changes in trends and pattern of strong opioid prescribing in primary care
10.1002/j.1532-2149.2014.496.x
Authors: C. Zin, L. Chen, R. Knaggs |
| 2023 |
Changes to healthcare utilisation and symptoms for common mental health problems over the first 21 months of the COVID-19 pandemic: parallel analyses of electronic health records and survey data in England
10.1016/j.lanepe.2023.100697
Authors: V. Taxiarchi, M. Senior, D. Ashcroft, M. Carr, H. Hope, M. Hotopf, E. Kontopantelis, S. McManus, P. Patalay, S. Steeg, R. Webb, K. Abel, M. Pierce |
| 2019 |
Changing causes of death for patients with chronic respiratory disease in England, 2005-2015
10.1136/thoraxjnl-2018-212514
Authors: A. Gayle, E. Axson, C. Bloom, V. Navaratnam, J. Quint |
| 2022 |
Changing co-morbidity and increasing deprivation among people living with HIV: UK population-based cross-sectional study
10.1111/hiv.13389
Authors: P. McGettigan, D. Morales, D. Moreno-Martos, N. Matin |
| 2016 |
Changing Epidemiology of Bariatric Surgery in the UK: Cohort Study Using Primary Care Electronic Health Records
10.1007/s11695-015-2032-9
Authors: H. Booth, O. Khan, A. Fildes, A. Prevost, M. Reddy, J. Charlton, M. Gulliford |
| 2009 |
Changing trends in antiepileptic drug prescribing in girls of child-bearing potential
10.1136/adc.2008.144386
Authors: R. Ackers, F. Besag, A. Wade, M. Murray, I. Wong |
| 2018 |
Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017
10.1136/bmjopen-2018-022768
Authors: S. Wilkinson, I. Douglas, H. Stirnadel-Farrant, D. Fogarty, A. Pokrajac, L. Smeeth, L. Tomlinson |
| 2020 |
Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen
10.1007/s40264-020-00950-3
Authors: R. Weinstein, P. Ryan, J. Berlin, M. Schuemie, J. Swerdel, D. Fife |
| 2017 |
Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications
10.1007/s40264-017-0581-7
Authors: R. Weinstein, P. Ryan, J. Berlin, A. Matcho, M. Schuemie, J. Swerdel, K. Patel, D. Fife |
| 2003 |
Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs
Authors: T. MacDonald, S. Morant, J. Goldstein, T. Burke, D. Pettitt |
| 2022 |
Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β(2)-agonist dual therapy in a primary care setting in England
10.1136/bmjresp-2022-001243
Authors: A. Czira, V. Banks, G. Requena, R. Wood, T. Tritton, R. Wild, C. Compton, M. Duarte, A. Ismaila |
| 2023 |
Characterising complex health needs and the use of preventive therapies in the older population: a population-based cohort analysis of UK primary care and hospital linked data
10.1186/s12877-023-03770-z
Authors: L. Elhussein, A. Jödicke, Y. He, A. Delmestri, D. Robinson, V . Y. Strauss, D. Prieto-Alhambra |
| 2021 |
Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study
10.1136/bmj.n1435
Authors: X. Li, A. Ostropolets, R. Makadia, A. Shoaibi, A. Rao, A. Sena, E. Martinez-Hernandez, K. Verhamme, P. Rijnbeek, P.B. Ryan, D. Prieto-Alhambra |
| 2023 |
Characterising the burden of chronic kidney disease among people with type 2 diabetes in England: a cohort study using the Clinical Practice Research Datalink
10.1136/bmjopen-2022-065927
Authors: S. Cook, N. Schmedt, J. Broughton, P. Kalra, L. Tomlinson, J. Quint |
